Dilip Shanghvi (born , Amreli, Gujarat state, India) is an Indian business executive who was the founder (1983) of Sun Pharmaceutical Industries Ltd. The son of a wholesale drug distributor, Shanghvi launched Sun Pharma soon after graduating (1982) from the University of Calcutta with a bachelor’s degree in commerce. He assumed the post of managing director. Initially, the ...
Reuters: China halts sale of Sun Pharma drug used to treat dementia
Invezz: Why is Sun Pharma betting $11.75B on a struggling US drugmaker?
Sun Pharma to buy Organon in $11.75 billion all-cash deal at $14 per share. Deal boosts presence in women’s health, biosimilars and innovative drugs. Transaction awaits approvals, with closing ...
Exploring the critical role of experimentation in Corporate Social Responsibility (CSR), research on four multinational companies reveals a stark difference in CSR effectiveness. Successful ...
As more companies commit to adopting CSR strategies that address environmental and social issues, it’s becoming more important than ever for these strategies to be goal-driven, ambitious yet ...
2023 will be a test of corporate America — the year we find out if corporate social responsibility (CSR) commitments and environmental, social, and governance (ESG) principles are deeply ...
Multinational firms face growing pressure to demonstrate positive societal impact in the frontier markets where they operate, yet many ESG and CSR initiatives fail to earn local trust—and ...
Traditional corporate social responsibility (CSR) programs have long felt like box-checking exercises—a bolt-on, or something driven mostly by public relations. But for leaders navigating an ...
Many companies care about corporate social responsibility (CSR). But putting it into practice requires more than CEO speeches and company policies; managers and employees have to be on board, so ...